Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-16-076144)

Filing Details

Accession Number:: 0001144204-16-076144
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-01-19 18:39:27
Reporting Period:: 2016-01-19

Filing Date:: 2016-01-19
Accepted Time:: 2016-01-19 18:39:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1208261	Immune Pharmaceuticals Inc	IMNP	Pharmaceutical Preparations (2834)	521841431

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1584822	Gedeon Daniel Teper	C/O Immune Pharmaceuticals Inc. 430 East 29Th Street, Suite 940 New York NY 10016	Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-01-19	44,200	$0.57	4,768,905	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The transaction reported in this line item was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2015.